UPC CFI 712/2025
7. Aug. 2025·EP1962668 · SANDWICH SENSOR FOR THE DETERMINATION OF AN ANALYTE CONCENTRATION
- Verfahrensdetails
- StatusCase ClosedVerfahrensartEinstweilige VerfügungKategorieEinstweilige Maßnahmen
- Parteien
- Kläger
- F. Hoffmann-La Roche AGUnternehmen
Vertreter- Christof Augenstein-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Svenja Ullmann-Kather Augenstein
- Matthias Stößelmitwirkend-Altmann Stößel Dick Patentanwälte PartGmbB
- Eva Hennekempermitwirkend-Altmann Stößel Dick Patentanwälte PartGmbB
Beklagte- A. Menarini Diagnostics s.r.l.Unternehmen
- Berlin-Chemie AGUnternehmen
- A.Menarini Diagnostics France SASUUnternehmen
Vertreter- Christopher Maierhöfer-Bird & Bird LLP
- Jan van Dieckmitwirkend-Bird & Bird LLP
- Leonard Lotzmitwirkend-Bird & Bird LLP
- Division
- Dusseldorf LD
- Technologie
- InstrumentsAnalysis of biological materials · Medical technology
- ChemistryBiotechnology
- Sprache
- German
- Erste Entscheidung
- 1. Okt. 2025
- Letzte Entscheidung
- 5. Dez. 2025
| Einstweilige Verfügung erlassen | Median Tage bis zur ersten Entscheidung | |
|---|---|---|
| Gesamt-UPC | 54% (38/70) | 124 |
| Dusseldorf LD | Gesperrt | Gesperrt |
| Richter Ronny Thomas | Gesperrt | Gesperrt |
| Richter Jule Schumacher | Gesperrt | Gesperrt |
| Richter András Kupecz | Gesperrt | Gesperrt |
| Richter Stefan Wilhelm | Gesperrt | Gesperrt |
Vor dem UPC: Roche Group (29 Verfahren)·A. Menarini Diagnostics s.r.l. (16 Verfahren)
Dieser Streit umfasst 2 weitere Verfahren
Starten Sie die kostenlose Testphase, um die Ausgänge zu sehen.
Weitere Verfahren: Dusseldorf LD·2025
- 2025-12-05Application for provisional measuresÖffentlich
Zusammenfassung: The Düsseldorf Local Division granted a preliminary injunction to Roche against A. Menarini Diagnostics for infringement of EP 1 962 668 B1 (implantable glucose sensor), ordering a recall and seizure of infringing sensors in France, Italy, and Germany, with an order to disclose distribution information and payment of EUR 32,051 provisional costs.
Rechtsfragen anzeigen (4)
- Preliminary injunction for implantable glucose sensor (CGM)
- Product claim vs. process claim scope
- Injunction covering manufacturing by third party outside contracting member states
- Seizure and recall in France, Italy, Germany
- 2025-10-01Application RoP262AÖffentlich
Zusammenfassung: The Düsseldorf Local Division (judge-rapporteur Dr. Schumacher) issued a confidentiality order under R. 262A RoP in the infringement proceedings brought by F. Hoffmann-La Roche AG and Roche Diabetes Care GmbH against A. Menarini Diagnostics entities concerning EP 1 962 668 B1 (glucose sensor).
Rechtsfragen anzeigen (2)
- Confidentiality order (R. 262A RoP)
- Glucose sensor patent infringement
| Dokumenttitel | Datum | Öffentlich |
|---|---|---|
| Verfahren abgeschlossen | 2026-04-20 | Nicht öffentlich |
| Veröffentlichung | 2025-12-08 | Nicht öffentlich |
| Order | 2025-12-08 | Öffentlich |
| Entscheidung | 2025-12-05 | Nicht öffentlich |
| Final Order | 2025-12-05 | Nicht öffentlich |
| Final Order | 2025-12-05 | Nicht öffentlich |
| Other Documents | 2025-11-17 | Nicht öffentlich |
| Anordnung | 2025-11-03 | Nicht öffentlich |
| Order | 2025-11-03 | Öffentlich |
| Mündliches Verfahren eröffnet | 2025-11-03 | Nicht öffentlich |
Roche (F. Hoffmann-La Roche AG and Roche Diabetes Care GmbH) obtained a preliminary injunction from the Düsseldorf Local Division against A. Menarini Diagnostics entities for infringement of EP 1 962 668 B1, covering an implantable sandwich sensor for glucose monitoring. The court issued a recall and seizure order in France, Italy, and Germany, set important headnotes on the relationship between product and process claims and on the territorial scope of manufacturing injunctions, and ordered EUR 32,051 provisional cost reimbursement.
Product claim scope is not limited by the corresponding independent process claim even where both are in the same patent
KlägerRechtsgrundlage: Headnote 1 of the orderHinweis: Court held that an independent process claim and its corresponding description are only relevant to the scope of a product claim if the specification indicates the process also describes characteristics of the claimed product.
An injunction covering 'making' of the infringing product can be issued even if manufacturing currently occurs outside UPC contracting states
KlägerRechtsgrundlage: Headnote 2 of the orderHinweis: Court confirmed that a manufacturing injunction may issue even where current production is by a third party outside contracting member states.
Menarini's implantable glucose sensor infringes EP 1 962 668 B1
KlägerRechtsgrundlage: Art. 62 UPCAHinweis: Preliminary injunction granted covering Germany, France, and Italy with recall, seizure, and disclosure orders.
Keine zurückgewiesenen Argumente erfasst.
Weitere Fälle zu diesem Grundsatz ansehen.
The Düsseldorf court addressed the relationship between an independent product claim and an independent process claim in EP 1 962 668 B1. It held that the process claim is relevant to the product claim's scope only to the extent the specification indicates the process also describes properties of the claimed product itself. This limits any attempt by the defendant to narrow the product claim by importing limitations from the process claim.